Prahlad Parajuli

Dr. Prahlad Parajuli

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2022 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
PPPrahlad Parajuli
Prahlad Parajuli
RRRayna Rosati
Rayna Rosati
HMHirva Mamdani
Hirva Mamdani
RWRobert E. Wright
Robert E. Wright
ZHZahin Hussain
Zahin Hussain
MRManohar Ratnam
Manohar Ratnam

11 December 2024 in Pediatric Allergy, Immunology, and Pulmonology
Verified
Journal Article
Closed access
YRYaddanapudi Ravindranath
Yaddanapudi Ravindranath
PPPrahlad Parajuli
Prahlad Parajuli

7 November 2026 in Genes
Verified
Journal Article
Open access
PDF file
YRYaddanapudi Ravindranath
Yaddanapudi Ravindranath
AHA. H. M. Mahbubul Huq
A. H. M. Mahbubul Huq
MNMadison Novice
Madison Novice
SGSudershan Kumar Grover
Sudershan Kumar Grover
YLYegappan Lakshmanan
Yegappan Lakshmanan
PPPrahlad Parajuli
Prahlad Parajuli
Poikiloderma with neutropenia, Clericuzio type (PN; OMIM #604173), is a rare autosomal recessive genodermatosis caused by biallelic loss-of-function variants in U6 snRNA Biogenesis 1 (USB1), with approximately 100 molecularly confirmed cases. Beyond the defining post-inflammatory poikiloderma and non-cyclic neutropenia, affected individuals show recurrent sinopulmonary infection, impaired wound healing, tendon contractures, and primary gonadal failure in males. USB1 is a 2H-superfamily 3′ to 5′ exoribonuclease that removes oligoadenylate tails added by Poly(A) polymerase associated protein 5 (PAPD5) and PAPD7; its loss destabilizes guide-strand microRNAs and blocks the emergence of CD45+ hematopoietic progenitors. Splicing is not measurably disturbed in patient cells, so the earlier splicing-centered account requires revision. Drawing on previously unpublished endocrine, neurologic and imaging data from two affected brothers, we develop a candidate model in which the microRNA lesion reaches cyclic nucleotide signaling by two routes: de-repression of phosphodiesterase E3B (PDE3B) after loss of miR-142-5p, and loss of a perinuclear and Golgi cyclic AMP compartment after coordinate reduction in A-kinase anchoring protein 6 (AKAP6) and PDE4D interacting protein (PDE4DIP). We state where the model is supported, where it conflicts with published effects, and what would refute it, arguing for compartment-restricted dysregulation rather than global deficiency. PAPD5/7 inhibition, leading to repression of PDE3B, is closest to the causal lesion, but its on-target neurotoxicity makes it an experimental tool rather than a candidate drug.

26 July 2022 in Research Square
Verified
Preprint
Open access
PDF file
PPPrahlad Parajuli
Prahlad Parajuli
RRRayna Rosati
Rayna Rosati
HMHirva Mamdani
Hirva Mamdani
RWRobert E Wright
Robert E Wright
ZHZahin Hussain
Zahin Hussain
MRManohar Ratnam
Manohar Ratnam
There is a need to improve response rates of immunotherapies in lung adenocarcinoma (AC). Extended (7–14 day) treatment of high glucocorticoid receptor (GR) expressing lung AC cells with dexamethasone (Dex) induces an irreversible senescence phenotype through chronic induction of p27. As the senescence associated secretory phenotype (SASP) may have either tumor supporting or antitumor immunomodulatory effects, it was of interest to examine the effects of Dex-induced senescence of lung AC cells on immune cells. Dex-induced senescence resulted in sustained production of CCL2, CCL4, CXCL1 and CXCL2, both in vitro and in vivo. After Dex withdrawal, secretion of these chemokines by the senescent cells attracted peripheral blood monocytes, T-cells, and NK cells. Following treatment with Dex-induced SASP protein(s), the peripheral blood lymphocytes exhibited higher cell count and tumor cytolytic activity along with enhanced Ki67 and perforin expression in T and NK cells. This cytolytic activity was partially attributed to NKG2D, which was upregulated in NK cells by SASP while its ligand MICA/B was upregulated in the senescent cells. Enhanced infiltrations of T ad NK cells were observed in human lung AC xenografts in humanized NSG mice, following treatment with Dex. The findings substantiate the idea that induction of irreversible senescence in high-GR expressing subpopulations of lung AC tumors using Dex pretreatment enhances tumor immune infiltration and may subsequently improve the clinical outcome of current immunotherapies.